Dr. Raoul Kopelman is the Richard Smalley Distinguished University Professor of Chemistry, Physics, and Applied Physics at The University of Michigan, Ann Arbor, as well as a member of the Biophysics Program, Biomedical Engineering and the the Michigan Nanotechnology Institute for Medicine and Biological Sciences, The Medical School. He obtained B.S. and Dipl. Eng. Degrees in Chemical Engineering from the Technion, Israel Institute of Technology, as well as an M.S. in Physical Chemistry. After having received a Ph.D. in Chemistry from Columbia University, he spent two years as research associate at Harvard University, two years as an instructor at the Technion, and two years as senior research fellow at the California Institute of Technology before coming to Michigan. He is a fellow of the American Physical Society and the American Association for the Advancement of Science, and has received, among others, the American Chemical Society’s Edward Morley Award and Medal (1997), as well as it’s Spectrochemical Analysis Award (2005). With his student, Jeff Anker, he also received the Hall of Fame Collegiate inventors Grand Prize (2002).
Professor Kopelman is the author of over 500 scientific papers, patents and books. Current research interests are in non-classical chemical reaction kinetics and in ultra-small opto-chemical sensors and actuators for biomedical use. Smart nanoprobes are being developed for the detection and therapy of cancer. Kopelman invented optical nanosensors for single cell chemical and physical imaging and is the inventor of multifunctional targeted nanoplatforms for the imaging and therapy of tumors, as well as a nanoscale photon source, a nanoscale voltmeter and a nanoscale viscometer. Professor Kopelman has been the principal investigator on projects of “Pathogen Nano-countermeasures”, “Nano-biomagnetics”, and “Nanoplatforms for Detection, Diagnostics and Treatment of Cancer”, as well as on numerous other projects from the National Institutes of Health, the National Cancer Institute, the National Science Foundation, the Defense Advanced Research Projects Administration, the Department of Energy and private foundations and companies. Presently he is the principal investigator on an NIH “Quantum Leap” grant, on “Nanoparticle enabled Intra-operative Imaging and Therapy”.
Dr. Kopelman brings to MNIMBS his expertise on nanochemistry, nanophysics, and nanotechnology and how to integrate those disciplines towards new and improved nanomedicine and medical nanodevices.
His website is: www.umich.edu/~koplab
|
